Pharmaline

10 records, newest first. Each line links to the FDA page it came from.

Refusal charges, in plain English

• POISONOUS4 refused lines

  Poisonous or deleterious substance

  The product appeared to bear or contain a poisonous or deleterious substance which may render it injurious to health.

• FALSE2 refused lines

  False or misleading labeling

  The labeling appeared to be false or misleading in some particular.

• NUTRIT LBL2 refused lines

  Nutrition information missing from label

  The label or labeling appeared not to carry the nutrition information that U.S. law requires for the food.

• DIETARYLBL1 refused line

  Not identified as a dietary supplement

  The label appeared not to identify the product with the term "dietary supplement" (which may be modified with the name of an ingredient).

• HEALTH C1 refused line

  Unauthorized nutrient content or health claim

  The label or labeling appeared to carry a nutrient content claim or health claim that is not authorized.

• LABELING1 refused line

  Fair Packaging and Labeling Act

  The package appeared not to meet the Fair Packaging and Labeling Act because of the placement, form, or contents of a required label statement.

• LACKS FIRM1 refused line

  Manufacturer name and address missing

  The packaged product's label appeared not to show the name and place of business of the manufacturer, packer, or distributor.

• NCONTACT1 refused line

  No U.S. adverse event contact on supplement label

  The dietary supplement label appeared not to show a U.S. address or phone number through which a serious adverse event can be reported.

Questions about Pharmaline

Is Pharmaline on an FDA import alert?

Yes. As of October 26, 2026, Pharmaline is on the red list of FDA Import Alert 99-39, “Imported foods that appear to be misbranded”, for fulvic care powder; FDA published the listing on December 10, 2021.

Has FDA refused shipments from Pharmaline?

Yes. FDA refused 7 shipment lines from Pharmaline between March 30, 2020 and March 26, 2024. The most recent, on March 26, 2024, was vitamin, mineral, proteins and unconventional dietary specialities for humans and animals, n.e.c., charged as NCONTACT (no u.s. adverse event contact on supplement label).

Why did FDA refuse Pharmaline's shipments?

The most frequent charges are POISONOUS (poisonous or deleterious substance, 4 lines) and FALSE (false or misleading labeling, 2 lines).

When was Pharmaline last inspected by FDA?

FDA's most recent inspection of Pharmaline with a final classification is dated February 1, 2024 and was classified NAI (No Action Indicated).

What is Pharmaline's FEI number?

Pharmaline's FDA Establishment Identifier (FEI) is 3011584394.

Can shipments from Pharmaline still enter the U.S.?

Shipments of fulvic care powder from Pharmaline can be detained without physical examination under Import Alert 99-39; FDA releases them only if evidence shows they do not have the listed violation. Importers must consider this listing in their FSVP evaluation (21 CFR 1.505).